Conavi Medical Corp.
CNVI.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -77.45% | 60.67% | -91.68% | -18.21% | 56.67% |
| Total Depreciation and Amortization | -3.21% | -6.09% | -0.60% | -5.04% | -5.25% |
| Total Amortization of Deferred Charges | 8.14% | -30.08% | -5.38% | -- | -- |
| Total Other Non-Cash Items | 117.27% | -202.77% | 365.22% | 61.69% | -220.71% |
| Change in Net Operating Assets | -498.94% | 196.64% | 81.73% | -330.49% | 231.10% |
| Cash from Operations | -58.62% | 15.87% | 35.51% | -120.60% | 59.20% |
| Capital Expenditure | 83.26% | -168.75% | -86.05% | 77.13% | 9.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.18% | -27.71% | -- | 100.00% | -100.18% |
| Cash from Investing | 25.29% | -43.25% | -1,588.37% | 81.86% | -100.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.86% | -61.13% | 29.67% | -14.75% | 13.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.35% | -- | -- |
| Cash from Financing | 2,237.02% | -31.98% | -102.03% | 5,108.20% | -103.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.50% | 11.59% | -153.35% | 362.19% | -184.96% |